Jeong JS - Search Results

1

In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.

Lee SJ, Lee SW, Jeong JS, Kim IH. Lee SJ, et al. Among authors: jeong js. Methods Mol Biol. 2010;629:307-21. doi: 10.1007/978-1-60761-657-3_20. Methods Mol Biol. 2010. PMID: 20387158

2

Changes in expression of cell cycle regulators after G1 progression upon repetitive thioacetamide treatment in rat liver.

Hong SH, Lee GD, Chung JY, Cho KS, Park SH, Kim IH, Jeong JS. Hong SH, et al. Among authors: jeong js. Exp Mol Med. 2002 Nov 30;34(5):361-6. doi: 10.1038/emm.2002.51. Exp Mol Med. 2002. PMID: 12526100

3

Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.

Kwon BS, Jung HS, Song MS, Cho KS, Kim SC, Kimm K, Jeong JS, Kim IH, Lee SW. Kwon BS, et al. Among authors: jeong js. Mol Ther. 2005 Nov;12(5):824-34. doi: 10.1016/j.ymthe.2005.06.096. Epub 2005 Jul 25. Mol Ther. 2005. PMID: 16040278 Free article.

4

In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.

Hong SH, Jeong JS, Lee YJ, Jung HI, Cho KS, Kim CM, Kwon BS, Sullenger BA, Lee SW, Kim IH. Hong SH, et al. Among authors: jeong js. Mol Ther. 2008 Jan;16(1):74-80. doi: 10.1038/sj.mt.6300282. Epub 2007 Aug 14. Mol Ther. 2008. PMID: 17700543 Free article.

5

Molecular imaging of endogenous mRNA expression in a mouse tumor model by adenovirus harboring trans-splicing ribozyme.

Hong SH, Jeong JS, Lee YJ, Jung HI, Kim KT, Kim YH, Lee YS, Lee SW, Bae CD, Park J, Kim IH. Hong SH, et al. Among authors: jeong js. FEBS Lett. 2007 Nov 27;581(28):5396-400. doi: 10.1016/j.febslet.2007.10.038. Epub 2007 Oct 30. FEBS Lett. 2007. PMID: 17976379 Free article.

6

Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.

Song MS, Jeong JS, Cho KS, Lee SW. Song MS, et al. Among authors: jeong js. Exp Mol Med. 2007 Dec 31;39(6):722-32. doi: 10.1038/emm.2007.79. Exp Mol Med. 2007. PMID: 18160843

7

Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.

Jeong JS, Lee SW, Hong SH, Lee YJ, Jung HI, Cho KS, Seo HH, Lee SJ, Park S, Song MS, Kim CM, Kim IH. Jeong JS, et al. Clin Cancer Res. 2008 Jan 1;14(1):281-90. doi: 10.1158/1078-0432.CCR-07-1524. Clin Cancer Res. 2008. PMID: 18172280

8

Intracellular efficacy of tumor-targeting group I intron-based trans-splicing ribozyme.

Kwon BS, Jeong JS, Won YS, Lee CH, Yoon KS, Hyung Jung M, Kim IH, Lee SW. Kwon BS, et al. Among authors: jeong js. J Gene Med. 2011 Feb;13(2):89-100. doi: 10.1002/jgm.1545. J Gene Med. 2011. PMID: 21322101

9

Selective and efficient retardation of cancers expressing cytoskeleton-associated protein 2 by targeted RNA replacement.

Ban G, Jeong JS, Kim A, Kim SJ, Han SY, Kim IH, Lee SW. Ban G, et al. Among authors: jeong js. Int J Cancer. 2011 Aug 15;129(4):1018-29. doi: 10.1002/ijc.25988. Epub 2011 Apr 13. Int J Cancer. 2011. PMID: 21328343

10

Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma.

Lee SJ, Kim SJ, Seo HH, Shin SP, Kim D, Park CS, Kim KT, Kim YH, Jeong JS, Kim IH. Lee SJ, et al. Among authors: jeong js. Cancer Lett. 2012 Jul 1;320(1):72-80. doi: 10.1016/j.canlet.2012.01.029. Epub 2012 Jan 21. Cancer Lett. 2012. PMID: 22269208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

649 results

Search Page

Filters